Autor: |
Siebert, Uwe, Jahn, Beate, Rochau, Ursula, Schnell-Inderst, Petra, Kisser, Agnes, Hunger, Theresa, Sroczynski, Gaby, Mühlberger, Nikolai, Willenbacher, Wolfgang, Schnaiter, Simon, Endel, Gottfried, Huber, Lukas, Gastl, Guenther |
Zdroj: |
Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen; January 2015, Vol. 109 Issue: 4-5 p330-340, 11p |
Abstrakt: |
The Oncotyrol– Center for Personalized Cancer Medicineis an international and interdisciplinary alliance combining research and commercial competencies to accelerate the development, evaluation and translation of personalized healthcare strategies in cancer. The philosophy of Oncotyrol is to collaborate with relevant stakeholders and advance knowledge “from bench to bedside to population and back”. Oncotyrol is funded through the COMET Excellence Programby the Austrian government via the national Austrian Research Promotion Agency (FFG). This article focuses on the role of health technology assessment (HTA) and outcomes research in personalized cancer medicine in the context of Oncotyrol. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|